Radiation/ nuclear medical countermeasure product development support
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N93020D00011
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 10 $96,204,935 obligated
Award facts
- Opportunity
-
- NIHAI201800019 Solicitation number
- Radiation/nuclear medical countermeasure product development support Award Notice · Posted Jul 14, 2020
- Combined order value
- $96,204,935 Current and potential, with all options
- Last date to order 90% complete
- IDV ceiling 96% used
- $100,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases awarded an indefinite-delivery contract to Sri International on July 1, 2020, with a $100 million ceiling for radiation and nuclear medical countermeasure product development support. This is a single-award IDIQ with an ultimate completion date of June 30, 2027.
Place of performance is Menlo Park, California. The originating solicitation covers radiation and nuclear medical countermeasure product development, including animal model development and efficacy testing of candidate medical countermeasures, non-clinical studies in support of IND/NDA/BLA submissions, and clinical safety studies for decorporation countermeasures.
The base performance period runs through June 30, 2027. As of the source date, government invoicing through FY2024 totaled $8.4 million. In FY2024, the order consumed 3.5 FTEs and 7,350 contractor hours at a derived government-paid rate of $372.06 per hour, with the hourly rate increasing from $233.87 per hour in FY2021.
Recent task-order activity includes a $16.2 million delivery order issued September 30, 2025, for animal model development and efficacy testing through September 29, 2027; a $3.6 million delivery order issued July 25, 2025, for non-clinical studies supporting IND/NDA/BLA submissions through July 20, 2027; and an $11.48 million delivery order issued July 1, 2020, for radiological and nuclear medical countermeasure product development support and technical support through June 30, 2027. Earlier orders include subcontracted work with Lovelace Biomedical Research Institute, the Medical College of Wisconsin, Charles River Laboratories, and Sloan-Kettering Institute for Cancer Research supporting animal model development and preclinical testing.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Subcontractor not on record | $126,000 | |
| Discovery Life Sciences, LLC | $69,155 | |
| Lovelace Biomedical Research Institute | $2,023,679 | |
| Rotunda Scientific Technologies LLC | $41,347 | |
| EPL Pathology Archives, LLC | $48,272 | |
| South Dakota State University | $67,942 | |
| Subcontractor not on record | $79,000 | |
| Jackson Laboratory | $38,289 | |
| EPL Pathology Archives, LLC | $34,534 | |
| Chromologic LLC | $229,548 | |
| Chromologic LLC | $108,065 | |
| Subcontractor not on record | $259,100 | |
| Experimental Pathology Laboratories, Inc. | $173,083 | |
| Trialwise Inc. | $336,771 | |
| Charles River Laboratories, Inc. | $114,900 | |
| Lovelace Biomedical Research Institute | $4,323,299 | |
| University Of Maryland, Baltimore | $4,370,586 | |
| The Medical College Of Wisconsin, Inc. | $372,536 | |
| Charles River Laboratories Montréal ULC | $1,148,699 | |
| CCS Associates, Inc. | $412,236 | |
| Quest Diagnostics Incorporated | $91,931 | |
| University Of Maryland, Baltimore | $6,116,876 |
Show all 22
Quick answers
Who was awarded contract 75N93020D00011?
75N93020D00011 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2020.
How much is contract 75N93020D00011 worth?
Orders under 75N93020D00011 have obligated $96,204,935. 75N93020D00011's own ceiling is $100,000,000.
How many orders have been placed under contract 75N93020D00011?
10 orders have been placed under 75N93020D00011, the latest on September 30, 2025.
Who can order from contract 75N93020D00011?
75N93020D00011 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N93020D00011 competed?
The extent of competition for 75N93020D00011 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV